荣昌生物制药（烟台）股份有限公司（股票代码：09995）于2026年5月6日发布截至2026年4月30日的股份变动月报表。报告期内，公司股本结构保持稳定，未出现新增发行、回购、注销或库存股份变动。
公司在4月底的法定（注册）股本总额为人民币564,477,483元，其中H股208,581,239股，A股355,896,244股。H股方面，上月底与本月底已发行股份保持208,581,239股不变。A股方面，本月底已发行股份及库藏股份分别维持在355,702,100股和194,144股，与上月底持平。
关于股权激励计划，公司在2022年及2023年分别通过相关A股股票激励计划，授出限制性股票，但本月并无新股实际发行或库藏股份转让，股数较上月未发生变化。
公司确认已遵守香港联合交易所有限公司证券上市规则下的公眾持股量要求。公告由董事王威东签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.